Fort Point Capital Partners LLC Amgen Inc Transaction History

Fort Point Capital Partners LLC

$874 Million
Q4 2024

A detailed history of Fort Point Capital Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 4,063 shares of AMGN stock, worth $1.18 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,063

Previous 3,895 4.31%

Holding current value

$1.18 Million

Previous $1.26 Million 15.7%

% of portfolio

0.12%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$258.78 - $328.31 $43,475 - $55,156	168 Added 4.31%	4,063 $1.06 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $44,860 - $48,920	-145 Reduced 3.59%	3,895 $1.26 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $202,580 - $246,188	-771 Reduced 16.03%	4,040 $1.26 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $196,121 - $221,248	-767 Reduced 13.75%	4,811 $1.39 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $17,054 - $21,173	78 Added 1.42%	5,578 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $200,342 - $236,900	935 Added 20.48%	5,500 $1.22 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $5,418 - $6,604	24 Added 0.53%	4,565 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $994 - $1,138	-5 Reduced 0.11%	4,541 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $7,004 - $8,207	33 Added 0.73%	4,546 $967,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $1,514 - $1,803	-7 Reduced 0.15%	4,513 $1.04 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $88,697 - $98,639	-378 Reduced 7.72%	4,520 $1.15 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $16,813 - $20,632	-85 Reduced 1.71%	4,898 $1.16 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $3,280 - $4,350	18 Added 0.36%	4,983 $1.01 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $8,335 - $9,770	-50 Reduced 1.0%	4,965 $915,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1,266 - $1,427	-7 Reduced 0.14%	5,015 $953,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 1.95%	5,022 $978,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $22,234 - $25,066	120 Added 2.4%	5,122 $1.06 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $23,745 - $26,670	-143 Reduced 2.78%	5,002 $923,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $60,825 - $71,082	-359 Reduced 6.52%	5,145 $877,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $86,589 - $96,746	513 Added 10.28%	5,504 $957,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $834,944 - $953,281	4,991	4,991 $931,000

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Account

Fort Point Capital Partners LLC Amgen Inc Transaction History